92 results
8-K
EX-99.1
AQST
Aquestive Therapeutics Inc
29 Apr 24
Other Events
9:30am
” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science … ) is a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:25am
company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies. We
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:23am
meaningful improvement to patients’ lives through innovative science and delivery technologies. We are developing pharmaceutical products to deliver
8-K
EX-99.2
ylwggdo1o mr3tp
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
8-K
EX-99.1
5j7r44 xy
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
424B5
5jz80nts zx
21 Mar 24
Prospectus supplement for primary offering
4:06pm
424B5
zbkpxg
19 Mar 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-99.1
xs8v8ht
5 Mar 24
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
5:09pm
8-K
EX-99.1
p2hd87m2q w97g
5 Dec 23
Other Events
8:51am
8-K
EX-99.1
qn6vmrcpmsw78p iy
8 Nov 23
Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. Corporate Presentation November 2023
5:04pm
8-K
EX-99.1
3ff9gh
6 Nov 23
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results
5:20pm
8-K
EX-99.1
o8urs
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
PRE 14A
xbbk0jz2ya0ktouw1
18 Apr 23
Preliminary proxy
8:50am
8-K
EX-99.1
iwv9rezpnsqrkz
28 Sep 22
Entry into a Material Definitive Agreement
9:37am